Article Gliosarcoma Is Driven by Alterations in PI3K/Akt, RAS/MAPK Pathways and Characterized by Collagen Gene Expression Signature Bartosz Wojtas 1, Bartlomiej Gielniewski 1, Kamil Wojnicki 1, Marta Maleszewska 1, Shamba S. Mondal 2, Pawel Nauman 3, Wieslawa Grajkowska 4, Rainer Glass 5, Ulrich Schüller 6,7,8, Christel Herold-Mende 9 and Bozena Kaminska 1,* 1 Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, 02-093 Warsaw, Poland;
[email protected] (B.W.);
[email protected] (B.G.);
[email protected] (K.W.);
[email protected] (M.M.) 2 Laboratory of Bioinformatics, Nencki Institute of Experimental Biology, Warsaw 02-093, Poland;
[email protected] 3 Department of Neurosurgery, Institute of Psychiatry and Neurology, Warsaw 02-957, Poland;
[email protected] 4 Department of Pathology, The Children's Memorial Health Institute, Warsaw 04-730, Poland;
[email protected] 5 Neurosurgical Research, University Clinics, LMU Munich 80539, Germany;
[email protected] 6 Institute of Neuropathology, University Medical Center, Hamburg-Eppendorf 20251, Germany;
[email protected] 7 Research Institute Children's Cancer Center Hamburg, Hamburg 20251, Germany 8 Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany 9 Division of Experimental Neurosurgery, Department of Neurosurgery, University of Heidelberg, Heidelberg 69120, Germany;
[email protected] * Correspondence:
[email protected]; Tel.: +48 22 5892209; Fax: +48 22 8225342 Received: 4 February 2019; Accepted: 19 February 2019; Published: 27 February 2019 Abstract: Gliosarcoma is a very rare brain tumor reported to be a variant of glioblastoma (GBM), IDH-wildtype.